Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss

Obesity Treatment

Lilly’s Triple‑Agonist Retatrutide Produces Surgery‑Level Weight Loss in Phase 3 Trial

Unusually large, sustained reductions reported by Lilly could reshape obesity treatment if regulators approve the drug this year.

CHMP Recommends Adding Oral Wegovy Tablets to EU Approval

BMJ Review Flags Rapid Weight Regain After GLP‑1 Stop as UK Approves Higher‑Dose Wegovy

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro